世界の再生医療市場2020年:企業別、地域別、種類・用途別

【英語タイトル】Global Regenerative Therapies Market 2020 by Company, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが出版した調査資料(GIR20SP01816)・商品コード:GIR20SP01816
・発行会社(調査会社):GlobalInfoResearch
・発行日:2020年9月18日(※2024年版があります。お問い合わせください)
・ページ数:101
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル
・産業分野:医療、製薬、バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥515,040見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥772,560見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,030,080見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートでは、再生医療の世界市場を広く調査・分析し、今後の市場展望をまとめております。再生医療の種類別市場規模(同種移植、異種移植、同種移植)、用途別市場規模(軟部組織修復、心臓血管系、歯科、整形外科、中枢神経系疾患治療、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。
・市場概要
・企業情報(販売量、市場シェア、製品概要、SWOT分析):Acelity、Athersys、Astellas Pharma、Mesoblast、Sanofi、Nuo Therapeutics、Cytori Therapeutics、Orgenesis、Organovo、Takeda
・地域別グローバル市場分析 2015年-2020年
・再生医療の北米市場(アメリカ、カナダ、メキシコ)
・再生医療のヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・再生医療のアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・再生医療の南米市場(ブラジル、アルゼンチン)
・再生医療の中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:同種移植、異種移植、同種移植
・用途別分析:軟部組織修復、心臓血管系、歯科、整形外科、中枢神経系疾患治療、その他
・地域別市場規模予測 2021年-2025年
・調査の結果・結論
【レポートの概要】

Market Overview
The global Regenerative Therapies market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Regenerative Therapies market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Regenerative Therapies market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Regenerative Therapies market has been segmented into:
Allografts
Xenografts
Alloplasts

By Application, Regenerative Therapies has been segmented into:
Soft Tissue Repair
Cardiovascular
Dental
Orthopaedic
CNS Disease Treatment
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Regenerative Therapies market presented in the report. This section sheds light on the sales growth of different regional and country-level Regenerative Therapies markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Regenerative Therapies market.

The report offers in-depth assessment of the growth and other aspects of the Regenerative Therapies market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Regenerative Therapies Market Share Analysis
Regenerative Therapies competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Regenerative Therapies sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Regenerative Therapies sales, revenue and market share for each player covered in this report.

The major players covered in Regenerative Therapies are:
Acelity
Athersys
Astellas Pharma
Mesoblast
Sanofi
Nuo Therapeutics
Cytori Therapeutics
Orgenesis
Organovo
Takeda

【レポートの目次】

Table of Contents

1 Regenerative Therapies Market Overview
1.1 Product Overview and Scope of Regenerative Therapies
1.2 Classification of Regenerative Therapies by Type
1.2.1 Global Regenerative Therapies Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Regenerative Therapies Revenue Market Share by Type in 2019
1.2.3 Allografts
1.2.4 Xenografts
1.2.5 Alloplasts
1.3 Global Regenerative Therapies Market by Application
1.3.1 Overview: Global Regenerative Therapies Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Soft Tissue Repair
1.3.3 Cardiovascular
1.3.4 Dental
1.3.5 Orthopaedic
1.3.6 CNS Disease Treatment
1.3.7 Others
1.4 Global Regenerative Therapies Market by Regions
1.4.1 Global Regenerative Therapies Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Regenerative Therapies (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Regenerative Therapies Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Regenerative Therapies Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Regenerative Therapies Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Regenerative Therapies Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Regenerative Therapies Status and Prospect (2015-2025)
2 Company Profiles
2.1 Acelity
2.1.1 Acelity Details
2.1.2 Acelity Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Acelity SWOT Analysis
2.1.4 Acelity Product and Services
2.1.5 Acelity Regenerative Therapies Revenue, Gross Margin and Market Share (2018-2019)
2.2 Athersys
2.2.1 Athersys Details
2.2.2 Athersys Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Athersys SWOT Analysis
2.2.4 Athersys Product and Services
2.2.5 Athersys Regenerative Therapies Revenue, Gross Margin and Market Share (2018-2019)
2.3 Astellas Pharma
2.3.1 Astellas Pharma Details
2.3.2 Astellas Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Astellas Pharma SWOT Analysis
2.3.4 Astellas Pharma Product and Services
2.3.5 Astellas Pharma Regenerative Therapies Revenue, Gross Margin and Market Share (2018-2019)
2.4 Mesoblast
2.4.1 Mesoblast Details
2.4.2 Mesoblast Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Mesoblast SWOT Analysis
2.4.4 Mesoblast Product and Services
2.4.5 Mesoblast Regenerative Therapies Revenue, Gross Margin and Market Share (2018-2019)
2.5 Sanofi
2.5.1 Sanofi Details
2.5.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Sanofi SWOT Analysis
2.5.4 Sanofi Product and Services
2.5.5 Sanofi Regenerative Therapies Revenue, Gross Margin and Market Share (2018-2019)
2.6 Nuo Therapeutics
2.6.1 Nuo Therapeutics Details
2.6.2 Nuo Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Nuo Therapeutics SWOT Analysis
2.6.4 Nuo Therapeutics Product and Services
2.6.5 Nuo Therapeutics Regenerative Therapies Revenue, Gross Margin and Market Share (2018-2019)
2.7 Cytori Therapeutics
2.7.1 Cytori Therapeutics Details
2.7.2 Cytori Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Cytori Therapeutics SWOT Analysis
2.7.4 Cytori Therapeutics Product and Services
2.7.5 Cytori Therapeutics Regenerative Therapies Revenue, Gross Margin and Market Share (2018-2019)
2.8 Orgenesis
2.8.1 Orgenesis Details
2.8.2 Orgenesis Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Orgenesis SWOT Analysis
2.8.4 Orgenesis Product and Services
2.8.5 Orgenesis Regenerative Therapies Revenue, Gross Margin and Market Share (2018-2019)
2.9 Organovo
2.9.1 Organovo Details
2.9.2 Organovo Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Organovo SWOT Analysis
2.9.4 Organovo Product and Services
2.9.5 Organovo Regenerative Therapies Revenue, Gross Margin and Market Share (2018-2019)
2.10 Takeda
2.10.1 Takeda Details
2.10.2 Takeda Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Takeda SWOT Analysis
2.10.4 Takeda Product and Services
2.10.5 Takeda Regenerative Therapies Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Regenerative Therapies Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Regenerative Therapies Players Market Share
3.2.2 Top 10 Regenerative Therapies Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Regenerative Therapies Revenue and Market Share by Regions
4.2 North America Regenerative Therapies Revenue and Growth Rate (2015-2020)
4.3 Europe Regenerative Therapies Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Regenerative Therapies Revenue and Growth Rate (2015-2020)
4.5 South America Regenerative Therapies Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Regenerative Therapies Revenue and Growth Rate (2015-2020)
5 North America Regenerative Therapies Revenue by Countries
5.1 North America Regenerative Therapies Revenue by Countries (2015-2020)
5.2 USA Regenerative Therapies Revenue and Growth Rate (2015-2020)
5.3 Canada Regenerative Therapies Revenue and Growth Rate (2015-2020)
5.4 Mexico Regenerative Therapies Revenue and Growth Rate (2015-2020)
6 Europe Regenerative Therapies Revenue by Countries
6.1 Europe Regenerative Therapies Revenue by Countries (2015-2020)
6.2 Germany Regenerative Therapies Revenue and Growth Rate (2015-2020)
6.3 UK Regenerative Therapies Revenue and Growth Rate (2015-2020)
6.4 France Regenerative Therapies Revenue and Growth Rate (2015-2020)
6.5 Russia Regenerative Therapies Revenue and Growth Rate (2015-2020)
6.6 Italy Regenerative Therapies Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Regenerative Therapies Revenue by Countries
7.1 Asia-Pacific Regenerative Therapies Revenue by Countries (2015-2020)
7.2 China Regenerative Therapies Revenue and Growth Rate (2015-2020)
7.3 Japan Regenerative Therapies Revenue and Growth Rate (2015-2020)
7.4 Korea Regenerative Therapies Revenue and Growth Rate (2015-2020)
7.5 India Regenerative Therapies Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Regenerative Therapies Revenue and Growth Rate (2015-2020)
8 South America Regenerative Therapies Revenue by Countries
8.1 South America Regenerative Therapies Revenue by Countries (2015-2020)
8.2 Brazil Regenerative Therapies Revenue and Growth Rate (2015-2020)
8.3 Argentina Regenerative Therapies Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Regenerative Therapies by Countries
9.1 Middle East & Africa Regenerative Therapies Revenue by Countries (2015-2020)
9.2 Saudi Arabia Regenerative Therapies Revenue and Growth Rate (2015-2020)
9.3 UAE Regenerative Therapies Revenue and Growth Rate (2015-2020)
9.4 Egypt Regenerative Therapies Revenue and Growth Rate (2015-2020)
9.5 South Africa Regenerative Therapies Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Regenerative Therapies Revenue and Market Share by Type (2015-2020)
10.2 Global Regenerative Therapies Market Forecast by Type (2019-2024)
10.3 Allografts Revenue Growth Rate (2015-2025)
10.4 Xenografts Revenue Growth Rate (2015-2025)
10.5 Alloplasts Revenue Growth Rate (2015-2025)
11 Global Regenerative Therapies Market Segment by Application
11.1 Global Regenerative Therapies Revenue Market Share by Application (2015-2020)
11.2 Regenerative Therapies Market Forecast by Application (2019-2024)
11.3 Soft Tissue Repair Revenue Growth (2015-2020)
11.4 Cardiovascular Revenue Growth (2015-2020)
11.5 Dental Revenue Growth (2015-2020)
11.6 Orthopaedic Revenue Growth (2015-2020)
11.7 CNS Disease Treatment Revenue Growth (2015-2020)
11.8 Others Revenue Growth (2015-2020)
12 Global Regenerative Therapies Market Size Forecast (2021-2025)
12.1 Global Regenerative Therapies Market Size Forecast (2021-2025)
12.2 Global Regenerative Therapies Market Forecast by Regions (2021-2025)
12.3 North America Regenerative Therapies Revenue Market Forecast (2021-2025)
12.4 Europe Regenerative Therapies Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Regenerative Therapies Revenue Market Forecast (2021-2025)
12.6 South America Regenerative Therapies Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Regenerative Therapies Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global Regenerative Therapies Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Regenerative Therapies by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Regenerative Therapies Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Regenerative Therapies Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Acelity Corporate Information, Location and Competitors
Table 6. Acelity Regenerative Therapies Major Business
Table 7. Acelity Regenerative Therapies Total Revenue (USD Million) (2017-2018)
Table 8. Acelity SWOT Analysis
Table 9. Acelity Regenerative Therapies Product and Solutions
Table 10. Acelity Regenerative Therapies Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Athersys Corporate Information, Location and Competitors
Table 12. Athersys Regenerative Therapies Major Business
Table 13. Athersys Regenerative Therapies Total Revenue (USD Million) (2018-2019)
Table 14. Athersys SWOT Analysis
Table 15. Athersys Regenerative Therapies Product and Solutions
Table 16. Athersys Regenerative Therapies Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Astellas Pharma Corporate Information, Location and Competitors
Table 18. Astellas Pharma Regenerative Therapies Major Business
Table 19. Astellas Pharma Regenerative Therapies Total Revenue (USD Million) (2017-2018)
Table 20. Astellas Pharma SWOT Analysis
Table 21. Astellas Pharma Regenerative Therapies Product and Solutions
Table 22. Astellas Pharma Regenerative Therapies Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Mesoblast Corporate Information, Location and Competitors
Table 24. Mesoblast Regenerative Therapies Major Business
Table 25. Mesoblast Regenerative Therapies Total Revenue (USD Million) (2017-2018)
Table 26. Mesoblast SWOT Analysis
Table 27. Mesoblast Regenerative Therapies Product and Solutions
Table 28. Mesoblast Regenerative Therapies Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Sanofi Corporate Information, Location and Competitors
Table 30. Sanofi Regenerative Therapies Major Business
Table 31. Sanofi Regenerative Therapies Total Revenue (USD Million) (2017-2018)
Table 32. Sanofi SWOT Analysis
Table 33. Sanofi Regenerative Therapies Product and Solutions
Table 34. Sanofi Regenerative Therapies Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Nuo Therapeutics Corporate Information, Location and Competitors
Table 36. Nuo Therapeutics Regenerative Therapies Major Business
Table 37. Nuo Therapeutics Regenerative Therapies Total Revenue (USD Million) (2017-2018)
Table 38. Nuo Therapeutics SWOT Analysis
Table 39. Nuo Therapeutics Regenerative Therapies Product and Solutions
Table 40. Nuo Therapeutics Regenerative Therapies Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Cytori Therapeutics Corporate Information, Location and Competitors
Table 42. Cytori Therapeutics Regenerative Therapies Major Business
Table 43. Cytori Therapeutics Regenerative Therapies Total Revenue (USD Million) (2017-2018)
Table 44. Cytori Therapeutics SWOT Analysis
Table 45. Cytori Therapeutics Regenerative Therapies Product and Solutions
Table 46. Cytori Therapeutics Regenerative Therapies Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Orgenesis Corporate Information, Location and Competitors
Table 48. Orgenesis Regenerative Therapies Major Business
Table 49. Orgenesis Regenerative Therapies Total Revenue (USD Million) (2017-2018)
Table 50. Orgenesis SWOT Analysis
Table 51. Orgenesis Regenerative Therapies Product and Solutions
Table 52. Orgenesis Regenerative Therapies Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Organovo Corporate Information, Location and Competitors
Table 54. Organovo Regenerative Therapies Major Business
Table 55. Organovo Regenerative Therapies Total Revenue (USD Million) (2017-2018)
Table 56. Organovo SWOT Analysis
Table 57. Organovo Regenerative Therapies Product and Solutions
Table 58. Organovo Regenerative Therapies Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Takeda Corporate Information, Location and Competitors
Table 60. Takeda Regenerative Therapies Major Business
Table 61. Takeda Regenerative Therapies Total Revenue (USD Million) (2017-2018)
Table 62. Takeda SWOT Analysis
Table 63. Takeda Regenerative Therapies Product and Solutions
Table 64. Takeda Regenerative Therapies Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Global Regenerative Therapies Revenue (Million USD) by Players (2015-2020)
Table 66. Global Regenerative Therapies Revenue Share by Players (2015-2020)
Table 67. Global Regenerative Therapies Revenue (Million USD) by Regions (2015-2020)
Table 68. Global Regenerative Therapies Revenue Market Share by Regions (2015-2020)
Table 69. North America Regenerative Therapies Revenue by Countries (2015-2020)
Table 70. North America Regenerative Therapies Revenue Market Share by Countries (2015-2020)
Table 71. Europe Regenerative Therapies Revenue (Million USD) by Countries (2015-2020)
Table 72. Asia-Pacific Regenerative Therapies Revenue (Million USD) by Countries (2015-2020)
Table 73. South America Regenerative Therapies Revenue by Countries (2015-2020)
Table 74. South America Regenerative Therapies Revenue Market Share by Countries (2015-2020)
Table 75. Middle East and Africa Regenerative Therapies Revenue (Million USD) by Countries (2015-2020)
Table 76. Middle East and Africa Regenerative Therapies Revenue Market Share by Countries (2015-2020)
Table 77. Global Regenerative Therapies Revenue (Million USD) by Type (2015-2020)
Table 78. Global Regenerative Therapies Revenue Share by Type (2015-2020)
Table 79. Global Regenerative Therapies Revenue Forecast by Type (2021-2025)
Table 80. Global Regenerative Therapies Revenue by Application (2015-2020)
Table 81. Global Regenerative Therapies Revenue Share by Application (2015-2020)
Table 82. Global Regenerative Therapies Revenue Forecast by Application (2021-2025)
Table 83. Global Regenerative Therapies Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Regenerative Therapies Picture
Figure 2. Global Regenerative Therapies Revenue Market Share by Type in 2019
Figure 3. Allografts Picture
Figure 4. Xenografts Picture
Figure 5. Alloplasts Picture
Figure 6. Regenerative Therapies Revenue Market Share by Application in 2019
Figure 7. Soft Tissue Repair Picture
Figure 8. Cardiovascular Picture
Figure 9. Dental Picture
Figure 10. Orthopaedic Picture
Figure 11. CNS Disease Treatment Picture
Figure 12. Others Picture
Figure 13. Global Regenerative Therapies Revenue (USD Million) and Growth Rate (2015-2025)
Figure 14. North America Regenerative Therapies Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Europe Regenerative Therapies Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Asia-Pacific Regenerative Therapies Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. South America Regenerative Therapies Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Middle East and Africa Regenerative Therapies Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Regenerative Therapies Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Global Regenerative Therapies Revenue Share by Players in 2019
Figure 21. Global Top 5 Players Regenerative Therapies Revenue Market Share in 2019
Figure 22. Global Top 10 Players Regenerative Therapies Revenue Market Share in 2019
Figure 23. Key Players Market Share Trend
Figure 24. Global Regenerative Therapies Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 25. Global Regenerative Therapies Revenue Market Share by Regions (2015-2020)
Figure 26. Global Regenerative Therapies Revenue Market Share by Regions in 2018
Figure 27. North America Regenerative Therapies Revenue and Growth Rate (2015-2020)
Figure 28. Europe Regenerative Therapies Revenue and Growth Rate (2015-2020)
Figure 29. Asia-Pacific Regenerative Therapies Revenue and Growth Rate (2015-2020)
Figure 30. South America Regenerative Therapies Revenue and Growth Rate (2015-2020)
Figure 31. Middle East and Africa Regenerative Therapies Revenue and Growth Rate (2015-2020)
Figure 32. North America Regenerative Therapies Revenue Market Share by Countries (2015-2020)
Figure 33. North America Regenerative Therapies Revenue Market Share by Countries in 2019
Figure 34. USA Regenerative Therapies Revenue and Growth Rate (2015-2020)
Figure 35. Canada Regenerative Therapies Revenue and Growth Rate (2015-2020)
Figure 36. Mexico Regenerative Therapies Revenue and Growth Rate (2015-2020)
Figure 37. Europe Regenerative Therapies Revenue Market Share by Countries (2015-2020)
Figure 38. Europe Regenerative Therapies Revenue Market Share by Countries in 2019
Figure 39. Germany Regenerative Therapies Revenue and Growth Rate (2015-2020)
Figure 40. UK Regenerative Therapies Revenue and Growth Rate (2015-2020)
Figure 41. France Regenerative Therapies Revenue and Growth Rate (2015-2020)
Figure 42. Russia Regenerative Therapies Revenue and Growth Rate (2015-2020)
Figure 43. Italy Regenerative Therapies Revenue and Growth Rate (2015-2020)
Figure 44. Asia-Pacific Regenerative Therapies Revenue Market Share by Countries (2015-2020)
Figure 45. Asia-Pacific Regenerative Therapies Revenue Market Share by Countries in 2019
Figure 46. China Regenerative Therapies Revenue and Growth Rate (2015-2020)
Figure 47. Japan Regenerative Therapies Revenue and Growth Rate (2015-2020)
Figure 48. Korea Regenerative Therapies Revenue and Growth Rate (2015-2020)
Figure 49. India Regenerative Therapies Revenue and Growth Rate (2015-2020)
Figure 50. Southeast Asia Regenerative Therapies Revenue and Growth Rate (2015-2020)
Figure 51. South America Regenerative Therapies Revenue Market Share by Countries (2015-2020)
Figure 52. South America Regenerative Therapies Revenue Market Share by Countries in 2019
Figure 53. Brazil Regenerative Therapies Revenue and Growth Rate (2015-2020)
Figure 54. Argentina Regenerative Therapies Revenue and Growth Rate (2015-2020)
Figure 55. Middle East and Africa Regenerative Therapies Revenue Market Share by Countries (2015-2020)
Figure 56. Middle East and Africa Regenerative Therapies Revenue Market Share by Countries in 2019
Figure 57. Saudi Arabia Regenerative Therapies Revenue and Growth Rate (2015-2020)
Figure 58. UAE Regenerative Therapies Revenue and Growth Rate (2015-2020)
Figure 59. Egypt Regenerative Therapies Revenue and Growth Rate (2015-2020)
Figure 60. South Africa Regenerative Therapies Revenue and Growth Rate (2015-2020)
Figure 61. Global Regenerative Therapies Revenue Share by Type (2015-2020)
Figure 62. Global Regenerative Therapies Revenue Share by Type in 2019
Figure 63. Global Regenerative Therapies Market Share Forecast by Type (2021-2025)
Figure 64. Global Allografts Revenue Growth Rate (2015-2020)
Figure 65. Global Xenografts Revenue Growth Rate (2015-2020)
Figure 66. Global Alloplasts Revenue Growth Rate (2015-2020)
Figure 67. Global Regenerative Therapies Revenue Share by Application (2015-2020)
Figure 68. Global Regenerative Therapies Revenue Share by Application in 2019
Figure 69. Global Regenerative Therapies Market Share Forecast by Application (2021-2025)
Figure 70. Global Soft Tissue Repair Revenue Growth Rate (2015-2020)
Figure 71. Global Cardiovascular Revenue Growth Rate (2015-2020)
Figure 72. Global Dental Revenue Growth Rate (2015-2020)
Figure 73. Global Orthopaedic Revenue Growth Rate (2015-2020)
Figure 74. Global CNS Disease Treatment Revenue Growth Rate (2015-2020)
Figure 75. Global Others Revenue Growth Rate (2015-2020)
Figure 76. Global Regenerative Therapies Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 77. Global Regenerative Therapies Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 78. Global Regenerative Therapies Revenue Market Share Forecast by Regions (2021-2025)
Figure 79. North America Regenerative Therapies Revenue Market Forecast (2021-2025)
Figure 80. Europe Regenerative Therapies Revenue Market Forecast (2021-2025)
Figure 81. Asia-Pacific Regenerative Therapies Revenue Market Forecast (2021-2025)
Figure 82. South America Regenerative Therapies Revenue Market Forecast (2021-2025)
Figure 83. Middle East and Africa Regenerative Therapies Revenue Market Forecast (2021-2025)
Figure 84. Sales Channel: Direct Channel vs Indirect Channel


【掲載企業】

Acelity、Athersys、Astellas Pharma、Mesoblast、Sanofi、Nuo Therapeutics、Cytori Therapeutics、Orgenesis、Organovo、Takeda

★調査レポート[世界の再生医療市場2020年:企業別、地域別、種類・用途別] (コード:GIR20SP01816)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の再生医療市場2020年:企業別、地域別、種類・用途別]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆